{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:34:56Z","timestamp":1792971296425,"version":"4.5.0"},"reference-count":337,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002568","name":"University of Ulsan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00438689"],"award-info":[{"award-number":["RS-2024-00438689"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00333606"],"award-info":[{"award-number":["RS-2024-00333606"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.preteyeres.2026.101496","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:25:13Z","timestamp":1784647513000},"page":"101496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drug delivery across the blood-retinal barrier: Biological gateways for posterior segment therapy"],"prefix":"10.1016","volume":"114","author":[{"given":"Jongwook","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Eun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunmo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaelin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonggyu","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeheung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-8033","authenticated-orcid":false,"given":"Junyeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2026.101496_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtos.2025.03.004","article-title":"Bringing ophthalmology into the scientific world: novel nanoparticle-based strategies for ocular drug delivery","volume":"37","author":"Abbasi","year":"2025","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.preteyeres.2026.101496_bib2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s13346-022-01196-5","article-title":"Light-responsive biomaterials for ocular drug delivery","volume":"13","author":"Abdelmohsen","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib3","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0161-6420(99)90406-2","article-title":"A phase I\/II study of subconjunctival carboplatin for intraocular retinoblastoma","volume":"106","author":"Abramson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib4","article-title":"Magnetically guided adeno-associated virus delivery for the spatially targeted transduction of retina in eyes","volume":"13","author":"Ahn","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2023.01.027","article-title":"Tailoring surface properties of liposomes for dexamethasone intraocular administration","volume":"354","author":"Al-Amin","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020312","article-title":"Deep learning prediction of response to Anti-VEGF among diabetic macular edema patients: treatment response analyzer system (TRAS)","volume":"12","author":"Alryalat","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114342","article-title":"Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies","volume":"187","author":"Alshaikh","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.carbon.2022.09.045","article-title":"Anti-angiogenic carbon nanovesicles loaded with bevacizumab for the treatment of age-related macular degeneration","volume":"201","author":"Anand","year":"2023","journal-title":"Carbon"},{"key":"10.1016\/j.preteyeres.2026.101496_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology","volume":"211","author":"Andr\u00e9s-Guerrero","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib10","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1021\/acs.molpharmaceut.5c00872","article-title":"Intravitreal sustained release of dexamethasone from a self-healing injectable hydrogel: an in vivo safety and release study","volume":"22","author":"Annala","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib11","doi-asserted-by":"crossref","first-page":"23463","DOI":"10.1074\/jbc.274.33.23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101496_bib12","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2337\/diabetes.47.12.1953","article-title":"Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn state retina research group","volume":"47","author":"Antonetti","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2026.101496_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108151","article-title":"Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: evaluation of the surface properties and effect on their distribution","volume":"198","author":"Apaolaza","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.150199","article-title":"Marine-derived polysaccharides enhance the drug delivery mechanism in the management of ocular diseases: a review","volume":"340","author":"Arokia Vijaya Anand","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11051-024-06199-6","article-title":"Recent advances and FDA approvals in nanoformulations for drug delivery","volume":"27","author":"Asadi","year":"2025","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib16","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/acs.chemrev.1c00622","article-title":"Ultrasound-responsive systems as components for smart materials","volume":"122","author":"Athanassiadis","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051444","article-title":"Real-time monitoring platform for ocular drug delivery","volume":"15","author":"Awwad","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1021\/acsnano.2c05447","article-title":"Repeated topical administration of 3 nm cerium oxide nanoparticles reverts disease atrophic phenotype and arrests neovascular degeneration in AMD mouse models","volume":"17","author":"Badia","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","article-title":"Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues","volume":"109","author":"Balguri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00360-3","article-title":"Iontophoresis and electroporation: comparisons and contrasts","volume":"179","author":"Banga","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib21","article-title":"Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases","volume":"8","author":"Bao","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2026.101496_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100586","article-title":"Safety and tolerability of suprachoroidal axitinib injectable suspension, for neovascular age-related macular degeneration; phase I\/IIa open-label, dose-escalation trial","volume":"5","author":"Barakat","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2026.101496_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2026.101496_bib24","first-page":"323","article-title":"Population pharmacokinetics of pegaptanib sodium (Macugen\u00ae) in patients with diabetic macular edema","volume":"9","author":"Basile","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"8","key":"10.1016\/j.preteyeres.2026.101496_bib25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0091270011412961","article-title":"Population pharmacokinetics of Pegaptanib in patients with neovascular, age\u2010related macular degeneration","volume":"52","author":"Basile","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx7204","article-title":"Healing of ischemic injury in the retina","volume":"12","author":"Becker","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101496_bib28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1167\/iovs.07-0767","article-title":"Evaluation of the new photosensitizer stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes","volume":"49","author":"Berdugo","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib29","first-page":"106","article-title":"Mapping the human blood-retinal barrier function","volume":"52","author":"Bernardes","year":"2005","journal-title":"IEEE (Inst. Electr. Electron. Eng.) Trans. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2026.101496_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch's membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23578","article-title":"Polymers and their engineered analogues for ocular drug delivery: enhancing therapeutic precision","volume":"115","author":"Biswas","year":"2024","journal-title":"Biopolymers"},{"key":"10.1016\/j.preteyeres.2026.101496_bib32","doi-asserted-by":"crossref","first-page":"35470","DOI":"10.1021\/acsomega.3c02897","article-title":"An update on strategies to deliver protein and peptide drugs to the eye","volume":"8","author":"Boddu","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.preteyeres.2026.101496_bib33","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/pharmaceutics15071896","article-title":"Efficacy and safety of low-intensity pulsed ultrasound-induced blood\u2013retinal barrier opening in mice","volume":"15","author":"Bourdin","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib34","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.preteyeres.2026.101496_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11222-006-8769-1","article-title":"A markov chain Monte Carlo version of the genetic algorithm differential evolution: easy Bayesian computing for real parameter spaces","volume":"16","author":"Braak","year":"2006","journal-title":"Stat. Comput."},{"key":"10.1016\/j.preteyeres.2026.101496_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","article-title":"Focused ultrasound-mediated drug delivery through the blood-brain barrier","volume":"15","author":"Burgess","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.preteyeres.2026.101496_bib37","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The <em>Lancet global health<\/em> Commission on Global eye health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.preteyeres.2026.101496_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10928-020-09713-0","article-title":"Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits","volume":"47","author":"Bussing","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"42","key":"10.1016\/j.preteyeres.2026.101496_bib39","doi-asserted-by":"crossref","first-page":"17817","DOI":"10.1073\/pnas.0908561106","article-title":"An experimental platform for systemic drug delivery to the retina","volume":"106","author":"Campbell","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib40","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ophtha.2012.04.030","article-title":"Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema","volume":"119","author":"Campochiaro","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202100127","article-title":"Cyclodextrin-assisted delivery of azobenzene photoswitches for uniform and long-term restoration of light responses in degenerated retinas of blind mice","volume":"4","author":"Cao","year":"2021","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.preteyeres.2026.101496_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12951-023-01794-6","article-title":"Intraocular delivery of ZIF-90-RhB-GW2580 nanoparticles prevents the progression of photoreceptor degeneration","volume":"21","author":"Cao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050237","article-title":"Ocular biodistribution studies using molecular imaging","volume":"11","author":"Castro-Balado","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.13.7.7","article-title":"Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues","volume":"13","author":"Chambers","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib46","first-page":"19649","article-title":"Multifunctional nanotherapeutics with long-acting release against macular degeneration by minimally invasive administration","volume":"18","author":"Chang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib47","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.preteyeres.2026.101496_bib48","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1111\/bph.13246","article-title":"A polyspecific drug\/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood\u2010retinal barrier","volume":"172","author":"Chapy","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bph.13376","article-title":"Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier","volume":"173","author":"Chapy","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.chempr.2023.02.013","article-title":"Photodynamic treatment of acute vascular occlusion by using an iron\u2013nitrosyl complex","volume":"9","author":"Choe","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.preteyeres.2026.101496_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400095","article-title":"Ophthalmic tethered gold yarnball-mediated retained drug delivery for eye fundus disease treatment","volume":"4","author":"Chou","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/physiol.00022.2012","article-title":"Endocytic receptors in the renal proximal tubule","volume":"27","author":"Christensen","year":"2012","journal-title":"Physiology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib54","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1167\/iovs.17-22431","article-title":"Systemic biodistribution and intravitreal pharmacokinetic properties of bevacizumab, ranibizumab, and aflibercept in a nonhuman primate model","volume":"58","author":"Christoforidis","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib55","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.5c20902","article-title":"Dual-pronged strategy on autoimmune uveitis by topical application of bioactive carbon dots from natural herbs","author":"Chu","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006982-200408000-00004","article-title":"Evaluation of photopoint photosensitizer MV6401, indium cgloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization","volume":"24","author":"Ciulla","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101496_bib58","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/acsnano.0c09115","article-title":"Harnessing endogenous stimuli for responsive materials in theranostics","volume":"15","author":"Cook","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122625","article-title":"Reverse engineering the ozurdex dexamethasone intravitreal implant","volume":"634","author":"Costello","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s44222-023-00082-0","article-title":"Self-assembled lipid\u2013prodrug nanoparticles","volume":"1","author":"Couvreur","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"6","key":"10.1016\/j.preteyeres.2026.101496_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.66.6.20","article-title":"Modeling the ocular pharmacokinetics and pharmacodynamics of Ranibizumab for improved understanding and data collection strategies in ocular diseases","volume":"66","author":"Crawshaw","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl. 6","key":"10.1016\/j.preteyeres.2026.101496_bib62","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101496_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081716","article-title":"Photodisruption of the inner limiting membrane: exploring ICG loaded nanoparticles as photosensitizers","volume":"14","author":"De Clerck","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejpb.2023.05.007","article-title":"Towards a population pharmacokinetic\/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration","volume":"188","author":"del Amo","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101496_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.13.11.13","article-title":"Ocular pharmacodynamics of intravitreal faricimab in patients with neovascular age-related macular degeneration or diabetic macular edema","volume":"13","author":"Diack","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101496_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.13.11.14","article-title":"Ocular pharmacokinetics of faricimab following intravitreal administration in patients with retinal disease","volume":"13","author":"Diack","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115481","article-title":"Drug delivery using gold nanoparticles","volume":"216","author":"Dykman","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101496_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.10.4.9","article-title":"Durability of VEGF suppression with intravitreal aflibercept and brolucizumab: Using pharmacokinetic modeling to understand clinical outcomes","volume":"10","author":"Eissing","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113703","article-title":"Efficacy and safety of ultrasound combined with microbubbles for treating retinal artery occlusion in rats","volume":"382","author":"Fan","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib72","article-title":"Peptide-bound aflibercept eye drops for treatment of neovascular age-related macular degeneration in nonhuman Primates","author":"Fan","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115321","article-title":"Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease","volume":"210","author":"Faria","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib74","article-title":"Pathologic vs. protective roles of hypoxia- inducible factor 1 in RPE and photoreceptors in wet vs. dry age- related macular degeneration","volume":"120","author":"Farrokhran","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.preteyeres.2026.101496_bib75","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.preteyeres.2026.101496_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1167\/tvst.9.8.43","article-title":"Ranibizumab population pharmacokinetics and free VEGF pharmacodynamics in preterm infants with retinopathy of prematurity in the RAINBOW Trial","volume":"9","author":"Fidler","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100803","article-title":"Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier","volume":"76","author":"Fields","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.preteyeres.2026.101496_bib79","series-title":"Guidance for Industry","article-title":"Liposome drug products: chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation","author":"Food","year":"2018"},{"key":"10.1016\/j.preteyeres.2026.101496_bib80","series-title":"Drug Products, Including Biological Products, that Contain Nanomaterials: Guidance for Industry","author":"Food","year":"2022"},{"key":"10.1016\/j.preteyeres.2026.101496_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","article-title":"Autoimmunity, autoinflammation, and infection in uveitis","volume":"189","author":"Forrester","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib82","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1167\/iovs.06-0532","article-title":"Evaluation of the new photosensitizer tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits","volume":"47","author":"Framme","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib83","first-page":"999","article-title":"Pericyte coverage of retinal and cerebral capillaries","volume":"31","author":"Frank","year":"1990","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib84","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/pharmaceutics15071862","article-title":"Innovative strategies for drug delivery to the ocular posterior segment","volume":"15","author":"Gabai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/pharmaceutics17050599","article-title":"Ocular drug delivery: emerging approaches and advances","volume":"17","author":"Gade","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202503503","article-title":"Molecular simulations of polymer-based drug nanocarriers: from physical and structural properties to controlled release","volume":"15","author":"Gao","year":"2026","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib87","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202570006","article-title":"Design of highly adhesive urchin-like gold nanostructures for effective topical drug administration and symptomatic relief of corneal dryness","volume":"6","author":"Ghosh","year":"2025","journal-title":"Small Struct."},{"key":"10.1016\/j.preteyeres.2026.101496_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2025.101634","article-title":"Hollow nanoarchitectures: materials engineering, nanochemistry, and biomedical applications","volume":"158","author":"Ghosh","year":"2026","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib90","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/ijms15011590","article-title":"Magnetic nanoparticles as intraocular drug delivery system to target retinal pigmented epithelium (RPE)","volume":"15","author":"Giannaccini","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/srep43092","article-title":"Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye","volume":"7","author":"Giannaccini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101496_bib92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/jacsau.4c01170","article-title":"Current understanding and translational prospects of tetrahedral framework nucleic acids","volume":"5","author":"Gu","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.preteyeres.2026.101496_bib93","article-title":"Photothermal transport for guiding nanoparticles through the vitreous humor","volume":"13","author":"Guerassimoff","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03804-z","article-title":"Toxicity analysis of gold nanoparticle formulations used for intraocular applications","volume":"15","author":"Hajrasouliha","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101496_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082870","article-title":"Bruch's membrane: a key consideration with complement-based therapies for age-related macular degeneration","volume":"12","author":"Hammadi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib96","article-title":"Methotrexate-loaded liposomal formulation enables 6-Week sustained intraocular therapeutic drug release in a porcine model","volume":"15","author":"Hammer","year":"2026","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib97","series-title":"Department of Medicine (Ophthalmology)","article-title":"Prediction of Anti-VEGF treatment outcome and recurrence in neovascular age-related macular degeneration based on optical coherence tomography using deep neural networks","author":"Han","year":"2025"},{"key":"10.1016\/j.preteyeres.2026.101496_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-023-00424-5","article-title":"The CLDN5 gene at the blood-brain barrier in health and disease","volume":"20","author":"Hashimoto","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.preteyeres.2026.101496_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101005","article-title":"Biomolecule-tailored assembly and morphology of gold nanoparticles for LSPR applications","volume":"35","author":"He","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.preteyeres.2026.101496_bib101","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1021\/acsabm.0c01334","article-title":"Laser-activated drug implant for controlled release to the posterior segment of the eye","volume":"4","author":"He","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2023.01.026","article-title":"Comparison of barrier properties of outer blood-retinal barrier models\u2013human stem cell-based models as a novel tool for ocular drug discovery","volume":"184","author":"Hellinen","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib103","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"Open"},{"key":"10.1016\/j.preteyeres.2026.101496_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ophtha.2021.09.016","article-title":"Archway randomized phase 3 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration","volume":"129","author":"Holekamp","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib106","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/17425247.2011.628983","article-title":"Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier","volume":"8","author":"Hosoya","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib107","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2509962","article-title":"Ophthalmic formulation of methotrexate: a strategy of using the self-assembled LacAC4A nanoparticles for non-invasive drug delivery to the ocular posterior segment","volume":"32","author":"Hou","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib108","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2026.101496_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s43586-023-00211-4","article-title":"Nanomaterial-based contrast agents","volume":"3","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.preteyeres.2026.101496_bib110","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1021\/acs.jafc.5c10713","article-title":"AFG ameliorates diabetic retinopathy through AMPK-dependent autolysosomal pathway: from network pharmacology to in vivo and in vitro validation","volume":"74","author":"Hu","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.preteyeres.2026.101496_bib111","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib112","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib113","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2017.06.009","article-title":"Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection","volume":"119","author":"Huang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2018.03.023","article-title":"Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility","volume":"118","author":"Huang","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/pharmaceutics14010074","article-title":"Efficient delivery of hydrophilic small molecules to retinal cell lines using gel core-containing solid lipid nanoparticles","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib116","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2023.06.024","article-title":"Retinal cell-targeted liposomal ginsenoside Rg3 attenuates retinal ischemia-reperfusion injury via alleviating oxidative stress and promoting microglia\/macrophage M2 polarization","volume":"206","author":"Huang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib117","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jop.2006.0135","article-title":"Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization","volume":"23","author":"Huang","year":"2007","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2026.101496_bib118","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jconrel.2022.05.009","article-title":"Penetrating-peptide-mediated non-invasive axitinib delivery for anti-neovascularisation","volume":"347","author":"Huang","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib119","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.drudis.2019.05.005","article-title":"Intravitreal nanoparticles for retinal delivery","volume":"24","author":"Huang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.preteyeres.2026.101496_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202407173","article-title":"The future of nanomaterials tackling the challenge of delivering nucleic acids to the retina","volume":"35","author":"Hurst","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib121","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/acs.molpharmaceut.7b00164","article-title":"Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model","volume":"14","author":"Hutton-Smith","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib122","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acs.molpharmaceut.5b00849","article-title":"A mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by ranibizumab in patients with neovascular age-related macular degeneration","volume":"13","author":"Hutton-Smith","year":"2016","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.preteyeres.2026.101496_bib123","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acs.molpharmaceut.5b00849","article-title":"A mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by ranibizumab in patients with neovascular age-related macular degeneration","volume":"13","author":"Hutton-Smith","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib124","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/b207789b","article-title":"Chemical synthesis of magnetic nanoparticles","author":"Hyeon","year":"2003","journal-title":"Chem. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2004.06.046","article-title":"Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications","volume":"24","author":"Hynynen","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.preteyeres.2026.101496_bib126","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/acs.molpharmaceut.3c00736","article-title":"Transferrin receptor-targeted Iduronate-2-sulfatase penetrates the blood-retinal barrier and improves retinopathy in mucopolysaccharidosis II mice","volume":"20","author":"Imakiire","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib127","series-title":"ICH Harmonised Tripartite Guideline: Pharmaceutical Development Q8(R2)","year":"2009"},{"key":"10.1016\/j.preteyeres.2026.101496_bib128","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1167\/iovs.02-1027","article-title":"Human retinal molecular weight exclusion limit and estimate of species variation","volume":"44","author":"Jackson","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98568-7","article-title":"Patient preferences in retinal drug delivery","volume":"11","author":"Jacobs","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101496_bib130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ophtha.2018.10.033","article-title":"Effect of an injectable fluocinolone acetonide insert on recurrence rates in chronic noninfectious uveitis affecting the posterior segment: twelve-Month results","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib131","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib132","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101496_bib133","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/pharmaceutics14030664","article-title":"Gold nanorods for drug and gene delivery: an overview of recent advancements","volume":"14","author":"Jahangiri-Manesh","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib134","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Jia","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib135","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jconrel.2020.01.036","article-title":"Injectable biodegradable bi-layered capsule for sustained delivery of bevacizumab in treating wet age-related macular degeneration","volume":"320","author":"Jiang","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib136","article-title":"A novel \u201cInside-Out\u201d Intraocular Nanomedicine Delivery Mode for Nanomaterials' biological effect enhanced choroidal neovascularization occlusion and microenvironment regulation","volume":"35","author":"Jin","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2016.09.008","article-title":"Nanoparticle-protein complexes mimicking corona formation in ocular environment","volume":"109","author":"Jo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2026.101496_bib138","doi-asserted-by":"crossref","first-page":"45405","DOI":"10.1021\/jacs.5c15651","article-title":"Glucose-Powered ultrasmall chemotactic nanorobots for retinal degeneration treatment","volume":"147","author":"Ju","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.preteyeres.2026.101496_bib139","volume":"vol. 67","author":"Jubran","year":"2020"},{"key":"10.1016\/j.preteyeres.2026.101496_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040445","article-title":"Intravitreal polymeric nanocarriers with long ocular retention and targeted delivery to the retina and optic nerve head Region","volume":"13","author":"Junnuthula","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib141","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/sj.gt.3302700","article-title":"Sustained expression after nonviral ocular gene transfer using mammalian promoters","volume":"13","author":"Kachi","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2026.101496_bib142","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2017.07.002","article-title":"Drug delivery devices for retinal diseases","volume":"128","author":"Kaji","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118722","article-title":"Physiologically-based pharmacokinetic modeling of enavogliflozin ophthalmic solution for starting dose selection in diabetic retinopathy treatment","volume":"193","author":"Kang","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101496_bib144","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biomaterials.2017.05.013","article-title":"Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy","volume":"136","author":"Kang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2026.101496_bib145","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2022.05.061","article-title":"Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions","volume":"349","author":"Kansara","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib146","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","article-title":"A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A","volume":"315","author":"Kawaguchi","year":"2007","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101496_bib147","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcph.2290","article-title":"Population pharmacokinetics of ranibizumab delivered via the port delivery system implanted in the eye in patients with neovascular age\u2010related macular degeneration","volume":"63","author":"K\u00e5gedal","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102394","article-title":"Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study","volume":"67","author":"Khanani","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.preteyeres.2026.101496_bib149","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/50\/505101","article-title":"Intravenously administered gold nanoparticles pass through the blood\u2013retinal barrier depending on the particle size, and induce no retinal toxicity","volume":"20","author":"Kim","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.actbio.2022.03.015","article-title":"Iontophoretic ocular delivery of latanoprost-loaded nanoparticles via skin-attached electrodes","volume":"144","author":"Kim","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib151","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","article-title":"Gelling hypotonic polymer solution for extended topical drug delivery to the eye","volume":"4","author":"Kim","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2026.101496_bib152","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jconrel.2009.10.031","article-title":"Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats","volume":"142","author":"Kim","year":"2010","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib153","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/pharmaceutics13010108","article-title":"Ocular drug delivery to the retina: current innovations and future perspectives","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100742","article-title":"Immunogenicity and potential for intraocular inflammation of intravitreal Anti-VEGF drugs","volume":"100","author":"Kim","year":"2024","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.preteyeres.2026.101496_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202317675","article-title":"Towards a light-mediated gene therapy for the eye using caged ethinylestradiol and the inducible Cre\/lox System","volume":"63","author":"Kiy","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.preteyeres.2026.101496_bib156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib157","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/lsm.1900150103","article-title":"Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization","volume":"15","author":"Kliman","year":"1994","journal-title":"Laser Surg. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib158","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.preteyeres.2017.04.004","article-title":"Roles of exosomes in the normal and diseased eye","volume":"59","author":"Klingeborn","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib159","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2026.101496_bib160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1520-7560(199907\/08)15:4<261::AID-DMRR43>3.0.CO;2-Z","article-title":"Glucose transport in brain and retina: implications in the management and complications of diabetes","volume":"15","author":"Kumagai","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.preteyeres.2026.101496_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010952","article-title":"Biocompatibility and cytotoxicity of gold nanoparticles: recent advances in methodologies and regulations","volume":"22","author":"Kus-Li\u015bkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib162","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s13346-025-01929-2","article-title":"Assessment of the orbit\u00ae subretinal delivery system (Orbit\u00ae SDS device) and prototypes in adult and juvenile canine eyes","volume":"16","author":"Kwok","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib163","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/pharmaceutics13040463","article-title":"Enhanced transport and permeation of a polymeric nanocarrier across the retina by mixing with ATP upon intravitreal injection","volume":"13","author":"Kwon","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib164","series-title":"3D Pharmacokinetic Modelling as a Tool for Ocular Drug Research and Development","author":"Lamminsalo","year":"2022"},{"key":"10.1016\/j.preteyeres.2026.101496_bib165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11095-018-2435-0","article-title":"Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: quantitative Analysis of Anterior and Posterior Elimination Pathways: lamminsalo et al","volume":"35","author":"Lamminsalo","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib166","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jconrel.2020.09.020","article-title":"Zero-order drug delivery: state of the art and future prospects","volume":"327","author":"Laracuente","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/polym13193324","article-title":"Hyaluronic acid-based gold nanoparticles for the topical delivery of therapeutics to the retina and the retinal pigment epithelium","volume":"13","author":"Laradji","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.preteyeres.2026.101496_bib168","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","article-title":"Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics","volume":"29","author":"Laude","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.preteyeres.2026.101496_bib169","first-page":"595","article-title":"Population pharmacokinetics and pharmacodynamics of lampalizumab administered intravitreally to patients with geographic atrophy","volume":"4","author":"Le","year":"2015","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib170","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/pharmaceutics16070914","article-title":"Clinical ocular exposure extrapolation for a complex ophthalmic suspension using physiologically based pharmacokinetic modeling and simulation","volume":"16","author":"Le Merdy","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib171","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12248-025-01138-2","article-title":"Clinical ocular exposure extrapolation for an ophthalmic ointment using PBPK modeling and simulation","volume":"27","author":"Le Merdy","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2026.101496_bib172","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41578-024-00767-x","article-title":"Design of oxide nanoparticles for biomedical applications","volume":"10","author":"Lee","year":"2025","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib173","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1021\/acs.chemrev.5b00112","article-title":"Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy","volume":"115","author":"Lee","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202114","article-title":"Acellularized Uvea hydrogel as novel injectable platform for cell-based delivering treatment of retinal degeneration and optimizing retinal organoids inducible System","volume":"11","author":"Li","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib175","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.nanolett.0c03756","article-title":"Brush conformation of polyethylene glycol determines the stealth effect of nanocarriers in the low protein adsorption regime","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.preteyeres.2026.101496_bib176","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/jps.23127","article-title":"MRI study of subconjunctival and intravitreal injections","volume":"101","author":"Li","year":"2012","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib177","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.xphs.2024.06.004","article-title":"Physiologically based pharmacokinetic modeling and clinical extrapolation for topical application of pilocarpine on eyelids: a comprehensive study","volume":"113","author":"Lin","year":"2024","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib178","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/smll.201202111","article-title":"Chemical design of biocompatible iron oxide nanoparticles for medical applications","volume":"9","author":"Ling","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.preteyeres.2026.101496_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113908","article-title":"Microneedle-mediated biomimetic nanoparticles for targeted antioxidant and anti-inflammatory therapy in age-related macular degeneration","volume":"384","author":"Liu","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib180","doi-asserted-by":"crossref","first-page":"35333","DOI":"10.1021\/acsnano.4c14313","article-title":"Disulfide-Appended siRNA nanoeyedrops: noninvasive gene therapy for targeting retinal angiogenesis","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib181","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1039\/D5CS00125K","article-title":"Photopharmacology and photoresponsive drug delivery","volume":"54","author":"Liu","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib182","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bjophthalmol-2019-315338","article-title":"Prediction of OCT images of short-term response to anti-VEGF treatment for neovascular age-related macular degeneration using generative adversarial network","volume":"104","author":"Liu","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib183","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/978-981-13-7647-4_10","article-title":"Roles of drug transporters in blood-retinal barrier","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib184","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1038\/s41467-023-43805-y","article-title":"Near-infrared light-triggered prodrug photolysis by one-step energy transfer","volume":"14","author":"Long","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib185","article-title":"Green light-triggered intraocular drug release for intravenous chemotherapy of retinoblastoma","volume":"8","author":"Long","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib186","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2020.06.024","article-title":"PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats","volume":"154","author":"Luaces-Rodriguez","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib187","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A","article-title":"Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown","volume":"49","author":"Luna","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib188","article-title":"Targeting nanocomposites with anti-oxidative\/inflammatory\/angiogenic activities for synergistically alleviating macular degeneration","volume":"24","author":"Luo","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.preteyeres.2026.101496_bib189","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2012.0138","article-title":"The vitreous humor as a barrier to nanoparticle distribution","volume":"29","author":"Mains","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2026.101496_bib190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib191","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1167\/iovs.06-1536","article-title":"Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function","volume":"48","author":"Mandell","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib192","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib193","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4067\/S0716-97602011000100012","article-title":"New insights into the roles of megalin\/LRP2 and the regulation of its functional expression","volume":"44","author":"Marzolo","year":"2011","journal-title":"Biol. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib194","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.21509","article-title":"Gold nanoparticles in ophthalmology","volume":"39","author":"Masse","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib195","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1021\/acsabm.4c00628","article-title":"Targeted 8-arm PEG nanosystems for localization of choroidal neovascularization macular degeneration model","volume":"7","author":"McLean","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib196","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s43246-026-01073-5","article-title":"Engineering the biophysical properties of lipid nanostructures for drug delivery","volume":"7","author":"Menge","year":"2026","journal-title":"Commun. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib197","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2024.05.034","article-title":"Phase 1\/2 AAV5-hRKp.RPGR (Botaretigene sparoparvovec) gene therapy: safety and efficacy in RPGR-Associated X-Linked retinitis pigmentosa","volume":"267","author":"Michaelides","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib198","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.drudis.2019.05.039","article-title":"Physiologically based ocular pharmacokinetic modeling using computational methods","volume":"24","author":"Missel","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.preteyeres.2026.101496_bib199","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd1662","article-title":"Healing sound: the use of ultrasound in drug delivery and other therapeutic applications","volume":"4","author":"Mitragotri","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2026.101496_bib200","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/s41598-023-32398-7","article-title":"Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network","volume":"13","author":"Moon","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101496_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2026.125223","article-title":"Recent advances in the polysaccharide nanogel design for dry eye therapy","volume":"382","author":"Mousavi","year":"2026","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.preteyeres.2026.101496_bib202","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-10960-9","article-title":"Peptide dendrimer and hyaluronic acid modified nanovesicles for ocular delivery of timolol maleate and siRNA","volume":"15","author":"Naik","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101496_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010211","article-title":"Tight junctions of the outer blood retina barrier","volume":"21","author":"Naylor","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib204","doi-asserted-by":"crossref","first-page":"40214","DOI":"10.1021\/acsami.1c03504","article-title":"Gold nanorod enhanced photoacoustic microscopy and optical coherence tomography of choroidal neovascularization","volume":"13","author":"Nguyen","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.preteyeres.2026.101496_bib205","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20276-z","article-title":"Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib206","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302069","article-title":"Renally clearable ultraminiature chain-like gold nanoparticle clusters for multimodal molecular imaging of choroidal neovascularization","volume":"35","author":"Nguyen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2026.101496_bib208","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.200302070","article-title":"Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice","volume":"161","author":"Nitta","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib209","doi-asserted-by":"crossref","first-page":"27888","DOI":"10.1021\/acsomega.3c07033","article-title":"Magnetically controlled intraocular delivery of dexamethasone using silica-coated magnetic nanoparticles","volume":"9","author":"Noh","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.preteyeres.2026.101496_bib210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s42003-019-0731-9","article-title":"Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates","volume":"3","author":"Normand","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib211","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp Alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2026.101496_bib212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib213","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib214","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s13346-025-01921-w","article-title":"Advancing nanoparticle delivery studies: flow cytometry-based quantification of nanoparticle uptake and transfection in retinal tissue","volume":"16","author":"Paoletti","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.preteyeres.2026.101496_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15296","article-title":"Plastic roles of pericytes in the blood-retinal barrier","volume":"8","author":"Park","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib217","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.14.10.6","article-title":"Computational fluid dynamics modeling of intravitreal ranibizumab bolus versus subretinal ABBV-RGX-314 transgene product in human eyes","volume":"14","author":"Park","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib218","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.13.5.5","article-title":"Focused ultrasound as a novel non-invasive method for the delivery of gold nanoparticles to retinal ganglion cells","volume":"13","author":"Park","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib219","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42004-025-01491-5","article-title":"Towards precision medicine using biochemically triggered cleavable conjugation","volume":"8","author":"Parshad","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.preteyeres.2026.101496_bib220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100527","article-title":"Phase I DAVIO trial: EYP-1901 bioerodible, sustained-delivery vorolanib insert in patients with wet age-related macular degeneration","volume":"4","author":"Patel","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2026.101496_bib222","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acs.molpharmaceut.6b00782","article-title":"LC-MS\/MS based quantitation of ABC and SLC transporter proteins in plasma membranes of cultured primary human retinal pigment epithelium cells and immortalized ARPE19 cell line","volume":"14","author":"Pelkonen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib223","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1167\/iovs.10-5984","article-title":"Claudin-19 and the barrier properties of the human retinal pigment epithelium","volume":"52","author":"Peng","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib224","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","article-title":"Morphology and composition of the inner limiting membrane: Species-Specific variations and relevance toward drug delivery research","volume":"44","author":"Peynshaert","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib225","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1167\/iovs.02-0287","article-title":"Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells","volume":"44","author":"Philp","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib226","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib227","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407340","article-title":"Progress in nanotechnology for treating ocular surface chemical injuries: reflecting on advances in ophthalmology","volume":"12","author":"Qi","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib228","article-title":"Wearable electrodriven switch actively delivers macromolecular drugs to fundus in non-invasive and controllable manners","volume":"16","author":"Qin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib230","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/10717544.2022.2069301","article-title":"The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery","volume":"29","author":"Ranade","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib231","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1364\/BOE.379150","article-title":"Deep learning-based single-shot prediction of differential effects of anti-VEGF treatment in patients with diabetic macular edema","volume":"11","author":"Rasti","year":"2020","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.preteyeres.2026.101496_bib232","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.preteyeres.2026.101496_bib233","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1021\/acs.biomac.0c00726","article-title":"Exploring the impact of morphology on the properties of biodegradable nanoparticles and their diffusion in complex biological medium","volume":"22","author":"Ridolfo","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.preteyeres.2026.101496_bib234","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmaceutics11010009","article-title":"Pharmacokinetic simulations of intravitreal biologicals: aspects of drug delivery to the posterior and anterior segments","volume":"11","author":"Rimpel\u00e4","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib235","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed Tomography\/Computed tomography imaging","volume":"13","author":"Rimpela","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib236","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.preteyeres.2011.06.002","article-title":"Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium","volume":"30","author":"Rizzolo","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib238","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1109\/JBHI.2020.3000136","article-title":"End-to-End deep learning model for predicting treatment requirements in neovascular AMD from longitudinal retinal OCT imaging","volume":"24","author":"Romo-Bucheli","year":"2020","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.preteyeres.2026.101496_bib239","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111782","article-title":"Ultrasound and microbubbles for the treatment of ocular diseases: from preclinical research towards clinical application","volume":"13","author":"Rousou","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041220","article-title":"Microbubble-Assisted ultrasound for drug delivery to the retina in an Ex vivo eye model","author":"Rousou","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/genes15060720","article-title":"Gene therapy for non-hereditary retinal disease: Age-Related macular degeneration, diabetic retinopathy, and beyond","volume":"15","author":"Rowe","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.preteyeres.2026.101496_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105115","article-title":"Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy","volume":"161","author":"Rudraraju","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101496_bib243","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/life12010033","article-title":"Distinct mechanisms of human retinal endothelial barrier modulation in vitro by mediators of diabetes and uveitis","volume":"12","author":"Rudraraju","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.preteyeres.2026.101496_bib244","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jconrel.2023.09.021","article-title":"Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration","volume":"363","author":"Ruiz","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib245","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2026.101496_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121800","article-title":"Imaging, quantitation and kinetic modelling of intravitreal nanomaterials","volume":"621","author":"Sadeghi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib247","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.65.11.28","article-title":"Mathematical models of ocular drug delivery","volume":"65","author":"Sadeghi","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib248","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2007.05.004","article-title":"Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer","volume":"122","author":"Sanders","year":"2007","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib249","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41565-022-01086-4","article-title":"Laser-induced nanobubbles safely ablate vitreous opacities in vivo","volume":"17","author":"Sauvage","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100972","article-title":"AI-based monitoring of retinal fluid in disease activity and under therapy","volume":"86","author":"Schmidt-Erfurth","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib251","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081157","article-title":"Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders","volume":"13","author":"Schneider-Futschik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib252","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41433-020-0770-y","article-title":"Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases","volume":"34","author":"Seah","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2026.101496_bib253","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/pharmaceutics13020225","article-title":"Efficient ocular delivery of VCP siRNA via reverse magnetofection in RHO P23H rodent retina explants","volume":"13","author":"Sen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib254","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13643-023-02261-x","article-title":"Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis","volume":"12","author":"Shahzad","year":"2023","journal-title":"Syst. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054957","article-title":"In situ Formation of injectable Gelatin methacryloyl (GelMA) hydrogels for effective intraocular delivery of triamcinolone acetonide","volume":"24","author":"Shen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib256","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib257","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl3576","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes","volume":"10","author":"Shen","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib258","doi-asserted-by":"crossref","first-page":"26200","DOI":"10.1021\/acsnano.5c08390","article-title":"Electrically driven chimeric extracellular vesicles crossing the fundus barrier for retinoblastoma treatment","volume":"19","author":"Shi","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102205","article-title":"Inhibition of choroidal neovascularization by systemic delivery of gold nanoparticles","volume":"28","author":"Singh","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib260","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2008.185","article-title":"Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV","volume":"16","author":"Singh","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2026.101496_bib261","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.3390\/jcm13237385","article-title":"Challenges in AAV-based retinal gene therapies and the role of magnetic nanoparticle platforms","volume":"13","author":"Siontas","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib262","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41572-025-00646-x","article-title":"Diabetic retinal disease","volume":"11","author":"Sivaprasad","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.preteyeres.2026.101496_bib263","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.omtm.2018.12.006","article-title":"Trans-ocular electric current in vivo enhances AAV-mediated retinal gene transduction after intravitreal vector administration","volume":"13","author":"Song","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib264","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.9.7.28","article-title":"Trans-ocular electric current in vivo enhances AAV-mediated retinal transduction in large animal eye after intravitreal vector administration","volume":"9","author":"Song","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib266","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188444","article-title":"Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release","volume":"12","author":"Stifter","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101496_bib267","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1167\/iovs.18-25667","article-title":"Selective ablation of megalin in the retinal pigment epithelium results in megaophthalmos, macromelanosome formation and severe retina degeneration","volume":"60","author":"Storm","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib268","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib269","doi-asserted-by":"crossref","first-page":"22793","DOI":"10.1021\/acsnano.4c08486","article-title":"Advances in extracellular-vesicles-based diagnostic and therapeutic approaches for ocular diseases","volume":"18","author":"Su","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-020-00745-9","article-title":"Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy","volume":"19","author":"Swetledge","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib271","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ncb1752","article-title":"Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5","volume":"10","author":"Taddei","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib272","volume":"9","author":"Tang","year":"2022","journal-title":"Ocular Nanomedicine. Advanced Science"},{"key":"10.1016\/j.preteyeres.2026.101496_bib273","article-title":"How liposomes pave the way for ocular drug delivery after topical administration","volume":"67","author":"Tasharrofi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib274","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib275","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2500Nature's lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib276","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2020.01.008","article-title":"Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations","volume":"148","author":"Thakur","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib277","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical Trials\u2014Tap report 1","volume":"117","author":"Group","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib278","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202507170","article-title":"Supramolecular self-assembled multivalent Anti-VEGF protein nanospheres for prolonged ocular retention","volume":"22","author":"Tian","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.preteyeres.2026.101496_bib279","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1167\/iovs.04-1175","article-title":"L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier","volume":"46","author":"Tomi","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib280","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2026.101496_bib281","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2011.304","article-title":"Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina","volume":"20","author":"Touchard","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2026.101496_bib282","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","article-title":"Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab","volume":"10","author":"Tyagi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101496_bib283","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12974-017-0905-7","article-title":"The carbon monoxide releasing molecule ALF-186 mediates anti-inflammatory and neuroprotective effects via the soluble guanylate cyclase \u00df1 in rats' retinal ganglion cells after ischemia and reperfusion injury","volume":"14","author":"Ulbrich","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101496_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114396","article-title":"Tiny tools, big vision: a minireview on carbonized nanomaterials in ophthalmology","volume":"388","author":"Unnikrishnan","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib285","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib286","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib287","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/jbm.a.35446","article-title":"Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment","volume":"103","author":"Varshochian","year":"2015","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia\u2013neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog. Retinal Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101496_bib289","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/D5PM00097A","article-title":"Unlocking the potential of exosomes \u2018extracellular vesicles\u2019: drug delivery advancements and therapeutics in ocular diseases","volume":"2","author":"Verma","year":"2025","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2026.101496_bib290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2018.05.030","article-title":"Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery","volume":"283","author":"Wang","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib291","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1021\/jacs.4c16529","article-title":"DNA framework-enabled ocular barrier penetration for microinvasive antiangiogenic therapy","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.preteyeres.2026.101496_bib292","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acsnano.4c12327","article-title":"Hybrid biomembrane-functionalized nanorobots penetrate the vitreous body of the eye for the treatment of retinal vein occlusion","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2026.101496_bib293","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1021\/acsomega.5c07330","article-title":"Tetrahedral DNA framework penetrating ocular barrier for treatment of retinal oxidative stress","volume":"10","author":"Wang","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.preteyeres.2026.101496_bib294","article-title":"Liposome-based permeable eyedrops for effective posterior segment drug delivery","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib295","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.2147\/IJN.S225992","article-title":"The application of methylprednisolone nanoscale zirconium-porphyrin metal-organic framework (MPS-NPMOF) in the treatment of photoreceptor degeneration","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.preteyeres.2026.101496_bib297","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1038\/s41467-025-64486-9","article-title":"Super mitochondria-enriched extracellular vesicles enable enhanced mitochondria transfer","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib298","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.2147\/IJN.S477011","article-title":"The Xaliproden Nanoscale Zirconium-Porphyrin metal-organic framework (XAL-NPMOF) promotes photoreceptor regeneration following oxidative and inflammatory insults","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.preteyeres.2026.101496_bib300","article-title":"Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib301","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41433-024-03134-w","article-title":"Sustained-release drug delivery systems","volume":"39","author":"Williams","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2026.101496_bib302","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/bdd.2276","article-title":"Blood retinal barrier and ocular pharmacokinetics: considerations for the development of oncology drugs","volume":"42","author":"Williamson","year":"2021","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.preteyeres.2026.101496_bib303","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202470194","article-title":"Innovative nanotechnology in drug delivery systems for advanced treatment of posterior segment ocular diseases","volume":"11","author":"Wu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib304","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat4388","article-title":"A swarm of slippery micropropellers penetrates the vitreous body of the eye","volume":"4","author":"Wu","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib305","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100421","article-title":"Impact of Anti-VEGF treatment and patient characteristics on vision outcomes in neovascular age-related macular degeneration: up to 6-Year analysis of the AAO IRIS\u00ae registry","volume":"4","author":"Wykoff","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2026.101496_bib306","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/24741264241267065","article-title":"Extended intraocular drug-delivery platforms for the treatment of retinal and choroidal diseases","volume":"8","author":"Wykoff","year":"2024","journal-title":"Journal of VitreoRetinal Diseases"},{"key":"10.1016\/j.preteyeres.2026.101496_bib307","article-title":"Size-evolving protein drug nanoparticles: a promising non-invasive strategy for retinal neovascularization by overcoming multiple ocular barriers","author":"Xie","year":"2026","journal-title":"Adv. Funct. Mater. n\/a"},{"issue":"3","key":"10.1016\/j.preteyeres.2026.101496_bib308","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1167\/iovs.12-10260","article-title":"Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: A population approach","volume":"54","author":"Xu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib309","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib310","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1049\/pel2.12551","article-title":"A mutually decoupled coil system to improve sensitivity of inductively coupled communication","volume":"16","author":"Xu","year":"2023","journal-title":"IET Power Electron."},{"key":"10.1016\/j.preteyeres.2026.101496_bib311","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2476140","article-title":"External stimuli-responsive drug delivery to the posterior segment of the eye","volume":"32","author":"Xu","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib312","article-title":"Red light-triggered anti-angiogenic and photodynamic combination therapy of age-related macular degeneration","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib313","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu5571","article-title":"Nanozyme eye drops for retinal barrier penetration and vasculopathy repair","volume":"11","author":"Xue","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib314","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082238","article-title":"Prediction of visual acuity in pathologic myopia with myopic choroidal neovascularization treated with anti-vascular endothelial growth factor using a deep neural network based on optical coherence tomography images","volume":"11","author":"Yang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2026.101496_bib315","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1038\/s41467-025-60454-5","article-title":"Synthetic carbon-based lanthanide upconversion nanoparticles for enhanced photothermal therapy","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib316","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2024.11.021","article-title":"Subretinal gene therapy drug AGTC-501 for XLRP phase 1\/2 multicenter Study (HORIZON): 24-Month safety and efficacy results","volume":"271","author":"Yang","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib317","article-title":"Enhanced ocular delivery of Beva via ultra-small polymeric micelles for noninvasive Anti-VEGF therapy","volume":"36","author":"Yang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib318","article-title":"Photoresponsive drug delivery systems: challenges and progress","volume":"34","author":"Yang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib319","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2014.09.030","article-title":"Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems","volume":"196","author":"Yasin","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101496_bib320","article-title":"Magnetic-guided delivery of antisense oligonucleotides for targeted transduction in multiple retinal explant and organoid models","author":"Ye","year":"2025","journal-title":"Advanced Science n\/a"},{"key":"10.1016\/j.preteyeres.2026.101496_bib321","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib322","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300531","article-title":"Hyaluronan-sphingosine polymersomes for treatment of ocular neovascularization: synthesis and evaluation","volume":"24","author":"Yetisgin","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib323","doi-asserted-by":"crossref","first-page":"14458","DOI":"10.1039\/D5NR01273B","article-title":"Current state and potential of polymersomes as ocular drug delivery systems","volume":"17","author":"Yetisgin","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.preteyeres.2026.101496_bib324","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/acs.chemrev.5c00245","article-title":"Gel-based ionic circuits","volume":"125","author":"Yoo","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.preteyeres.2026.101496_bib325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.14.1.7","article-title":"Pulsed ultrasound-mediated drug delivery enhancement through human sclera","volume":"14","author":"You","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib326","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jop.2022.0114","article-title":"Pulsed ultrasound-mediated enhancement on transscleral and transconjunctival fluorescein sodium delivery to rabbit eye in vivo","volume":"39","author":"You","year":"2023","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2026.101496_bib327","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101496_bib328","doi-asserted-by":"crossref","DOI":"10.1002\/rpm2.70029","article-title":"Stimuli-responsive systems: a focus on controlled drug delivery for posterior segment ocular disease","volume":"3","author":"Zhang","year":"2025","journal-title":"Responsive Materials"},{"key":"10.1016\/j.preteyeres.2026.101496_bib329","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01596-1","article-title":"Small intracellular vesicles outperform small extracellular vesicles in uptake, drug delivery and retinal neuroprotection","author":"Zhang","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2026.101496_bib330","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41467-026-69077-w","article-title":"A combinatorial synthetic strategy for developing genome-editing protein-delivery agents targeting mouse retina","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101496_bib331","article-title":"RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.preteyeres.2026.101496_bib332","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2025.104635","article-title":"Predicting response to anti-VEGF therapy in neovascular age-related macular degeneration using random forest and SHAP algorithms","volume":"53","author":"Zhang","year":"2025","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2026.101496_bib333","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1167\/iovs.17-23632","article-title":"Three-dimensional transport model for intravitreal and suprachoroidal drug injection","volume":"59","author":"Zhang","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib334","article-title":"Magnetically guided microrobots for targeted drug delivery","author":"Zhang","year":"2026","journal-title":"Advanced Healthcare Materials n\/a"},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101496_bib335","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.ophtha.2014.05.012","article-title":"Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema","volume":"121","author":"Zhang","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101496_bib336","article-title":"A hydrogel ionic circuit based high-intensity iontophoresis device for intraocular macromolecule and nanoparticle delivery","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib337","article-title":"In situ crystallized ceria-Vesicle nanohybrid therapeutic for effective treatment of inflammatory intraocular disease","volume":"14","author":"Zhao","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib338","article-title":"Harnessing semen-derived exosomes for noninvasive fundus drug delivery: a paradigm for exosome-based ocular fundus therapeutics","volume":"12","author":"Zhao","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101496_bib339","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12248-025-01052-7","article-title":"An ocular exposure prediction for topical atropine in human using physiologically based pharmacokinetic modeling","volume":"27","author":"Zheng","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2026.101496_bib340","article-title":"A glucose-responsive hydrogel inhibits primary and secondary BRB injury for retinal microenvironment remodeling in diabetic retinopathy","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.preteyeres.2026.101496_bib341","article-title":"Recent advances in nanomedicine for ocular fundus neovascularization disease management","volume":"13","author":"Zhou","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.preteyeres.2026.101496_bib342","first-page":"11616","article-title":"Therapeutic effect of baicalin-loaded thermosensitive liposomal hydrogel in autoimmune uveitis","volume":"11","author":"Zhu","year":"2026","journal-title":"ACS Omega"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:26:27Z","timestamp":1792970787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946226000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":337,"alternative-id":["S1350946226000625"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101496","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery across the blood-retinal barrier: Biological gateways for posterior segment therapy","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101496"}}